EVLV earnings analysis
What we found in EVLV's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Evolv delivered Q2 revenue of $43.753 million, representing approximately 33% year-over-year growth and a $2.1 million consensus beat, but revenue declined approximately 5% sequentially and GAAP diluted EPS was $(0.05). Management raised 2026 revenue and ARR outlook and introduced $15 million-$16 million of Adjusted EBITDA guidance. However, unresolved material weaknesses, a $402.1 million accumulated deficit, $30.0 million of term debt, ongoing regulatory exposure and covenant requirements materially temper the operating momentum.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue grew 33% year over year
- Q2 revenue was $43.753 million, up approximately 32.6% from $33 million in Q2 2025, although down approximately 4.9% from $46 million in Q1 2026.
- Revenue beat consensus by $2.1M
- Revenue exceeded the $41.635 million consensus estimate by approximately $2.1 million, or 5.1%.
- Adjusted EPS beat estimates
- Adjusted diluted EPS was $(0.02), better than the $(0.03) consensus estimate by $0.01; GAAP diluted EPS was $(0.05).
- Full-year outlook was raised
- Management raised 2026 revenue guidance to $180 million-$185 million from $175 million-$180 million and introduced Adjusted EBITDA guidance of $15 million-$16 million.
- ARR and subscription mix outlook improved
- Ending ARR guidance increased to $148 million-$150 million from $145 million-$150 million, while expected purchase-subscription deployments increased to approximately 60% from 55%.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Material weaknesses remain unresolved
- Management concluded that disclosure controls were not effective as of June 30, 2026 and identified material weaknesses across the control environment, risk assessment, period-end reporting, complex transactions, accounting policies, and IT general controls. Prior financial statements were restated for annual periods ended December 31, 2022 and 2023 and quarterly periods beginning in Q2 2022.
- Persistent losses and accumulated deficit
- The company reported net losses of $14.3 million for the six months ended June 30, 2026 and $42.2 million for the comparable 2025 period, with an accumulated deficit of $402.1 million as of June 30, 2026.
- Debt and covenant constraints
- As of June 30, 2026, $30.0 million of initial term-loan debt was outstanding, while a $30.0 million delayed-draw facility and $15.0 million revolver remained undrawn and available. The facilities include minimum ARR and liquidity covenants, with a minimum EBITDA covenant taking effect June 30, 2027.
- Evolving AI regulation raises costs
- The company’s AI-related risk exposure has expanded as regulations develop: the EU AI Act imposes requirements for high-risk applications beginning August 2, 2027, and the Colorado AI law became effective June 30, 2026.
- AI component demand pressures supply
- AI-driven semiconductor demand is straining component capacity and supplier availability, potentially increasing shortages, lead times and cost volatility for components used in the company’s products.
- Founder-share dispute may add volatility
- On July 16, 2026, 1,897,500 contingently returnable founder shares were forfeited, and a portion had not been returned for cancellation as of the filing; recurring fair-value changes on unreturned shares could materially affect earnings.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.05
What they said about what is next.
The company raised 2026 revenue guidance to $180 million-$185 million from $175 million-$180 million, increased ending ARR guidance to $148 million-$150 million from $145 million-$150 million, and introduced Adjusted EBITDA guidance of $15 million-$16 million. Expected purchase-subscription deployments were raised to approximately 60% from 55%.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 12, 2026
- Evolv Technology reported strong Q1 2026 results, with revenue reaching $46.3 million, a 45% increase year-over-year, surpassing estimates by 5.8%. Despite an EPS loss of $0.02, the company raised its revenue guidance…
- 10-K · March 10, 2026
- Evolv’s 2025 10-K emphasizes its hardware-enabled Security-as-a-Service strategy (proprietary AI, cloud analytics, and subscriptions) and highlights scale (over 4 billion visitors screened) and a large addressable…
- 10-Q · August 14, 2025
- Evolv reported quarterly revenue of $32,544,000 (up $7,320,000 or 29.0% vs Q2 2024's $25,224,000) driven by subscription growth, but reported a GAAP net loss and EPS deterioration driven by large non‑cash fair‑value…
- 10-K · April 28, 2025
- Evolv positions itself as an AI-powered, cloud-connected security screening company selling hardware + multi-year Security-as-a-Service subscriptions (flagship Evolv Express and new Evolv eXpedite). Deployment metrics…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing EVLV makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever